QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that Peer M. Schatz, Chief Executive Officer, has notified the Company that, after 27 years at QIAGEN, he has decided to step down as Chief Executive Officer and Chairman of the Management Board. He will remain with QIAGEN as Special Advisor to the Supervisory Board and transition into this role in the coming weeks. The Supervisory Board will now start a search for a permanent CEO. In the meantime, Thierry Bernard, Senior Vice President, Head of Molecular Diagnostics Business Area, will now act as interim CEO and work in tandem with Roland Sackers, Chief Financial Officer.
{iframe}https://markets.businessinsider.com/news/stocks/qiagen-announces-ceo-leadership-transition-1028581390{/iframe}